ACON Aclarion, Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine.

$0.88
As of 06/28/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Health Information Services
Index country:  USA
Country of incorporation:  
IPO date:  04/22/2022
Outstanding shares:  7,821,515
Average volume:  108,632
Market cap:   $7,039,364
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -2.06
PB ratio:   -1.23
PS ratio:   160.36
Return on equity:   63.60%
Net income %:   -16,601.79%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy